Task 2 AAV9-GRD-C24 vs AAV-K55-GRD-C24 efficacy (single dose, single time point) Body Weight.pptx

syn70747580

Created By Karis Weisgerber karisweisgerber

Id: e1c6f9b5-df93-4c92-9162-d3245176a9c2
sex: Female
assay: survival
organ: nerves
species: Mus musculus
studyId: syn31821155
dataType: physiology parameter
entityId: syn70747580
Component: ClinicalAssayTemplate
diagnosis: Not Applicable
studyName: NTAP NF1 Gene Replacement Initiative- Development of a gene replacement therapy for cutaneous neurofibromas related to NF1
tumorType: Not Applicable
fileFormat: powerpoint
initiative: Gene Replacement Initiative
dataSubtype: processed
compoundDose: 2
compoundName: K55-GRD-C24
individualID: A766 A767 A768 A769 A770 A761 A762 A763 A764 A765
resourceType: result
fundingAgency: NTAP
timepointUnit: weeks
compoundDoseUnit: 1000000000000.0
experimentalCondition: Two dosages of 1e12 K55-GRD-C24 (Day 0, Day7) through tail vein

Task 2 AAV9-GRD-C24 vs AAV-K55-GRD-C24 efficacy (single dose, single time point) Body Weight.pptx page is loading…